Search Results

Ghrelin receptor modulators and their therapeutic potential

Authors: Costantino, Luca; Barlocco, Daniela

Source: Future Medicinal Chemistry, Volume 1, Number 1, April 2009 , pp. 157-177(21)

Publisher: Future Science

Human TSH receptor ligands as pharmacological probes with potential clinical application

Authors: Neumann, Susanne; Raaka, Bruce M; Gershengorn, Marvin C

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 6, November 2009 , pp. 669-679(11)

Publisher: Expert Reviews

Thyroid hormone β receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys

Authors: Ito, BR; Zhang, B-H; Cable, EE; Song, X; Fujitaki, JM; MacKenna, DA; Wilker, CE; Chi, B; van Poelje, PD; Linemeyer, DL; Erion, MD

Source: British Journal of Pharmacology, Volume 156, Number 3, February 2009 , pp. 454-465(12)

Publisher: Blackwell Publishing

Neuroendocrine Regulation of Thyroid-stimulating Hormone Secretion in Amphibians

Authors: Okada, Reiko; Kobayashi, Tetsuya; Yamamoto, Kazutoshi; Nakakura, Takashi; Tanaka, Shigeyasu; Vaudry, Hubert; Kikuyama, Sakae

Source: Annals of the New York Academy of Sciences, Volume 1163, Number 1, April 2009 , pp. 262-270(9)

Publisher: Blackwell Publishing

Editorial [Hot Topic:The Calcium-Sensing Receptor: Pathophysiology and Pharmacological Modulation(Guest Editor: Ubaldo Armato)]

Author: Armato, Ubaldo

Source: Current Pharmaceutical Biotechnology, Volume 10, Number 3, April 2009 , pp. 268-269(2)

Publisher: Bentham Science Publishers

Chemistry and Biology of Thyrotropin-Releasing Hormone (TRH) and its Analogs

Authors: Monga, Vikramdeep; Meena, Chhuttan L.; Kaur, Navneet; Jain, Rahul

Source: Current Medicinal Chemistry, Volume 15, Number 26, November 2008 , pp. 2718-2733(16)

Publisher: Bentham Science Publishers

Treatment of Anaplastic Thyroid Cancer: Is there a Role for PPARγ Agonists?

Authors: Antonelli, Alessandro; Ferrari, Silvia M.; Fallahi, Poupak; Berti, Piero; Materazzi, Gabriele; Ghiri, Emiliano; Carpi, Angelo; Nicolini, Andrea; Miccoli, Paolo

Source: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Volume 2, Number 3, November 2008 , pp. 194-199(6)

Publisher: Bentham Science Publishers

Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential

Authors: Zimber, Amazia; Gespach, Christian

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 8, Number 5, June 2008 , pp. 540-563(24)

Publisher: Bentham Science Publishers

Editorial [ HPA Axis Guest Editor: Brian Dyck ]

Author: Dyck, Brian

Source: Current Topics in Medicinal Chemistry, Volume 8, Number 6, April 2008 , pp. 505-505(1)

Publisher: Bentham Science Publishers

Thyroid hormone receptor subtype-β-selective agonists as potential treatments for metabolic syndrome

Authors: Grover, Gary J; Kelly, Jane; Malm, Johan

Source: Future Lipidology, Volume 2, Number 6, December 2007 , pp. 641-649(9)

Publisher: Future Medicine

Impact of Weight-Loss Medications on the Cardiovascular System: Focus on Current and Future Anti-Obesity Drugs

Authors: Drolet, Benoit; Simard, Chantale; Poirier, Paul

Source: American Journal of Cardiovascular Drugs, Volume 7, Number 4, 2007 , pp. 273-288(16)

Publisher: Adis International

Targeting CCK Receptors in Human Cancers

Author: Jean Claude Reubi,

Source: Current Topics in Medicinal Chemistry, Volume 7, Number 12, June 2007 , pp. 1239-1242(4)

Publisher: Bentham Science Publishers

Therapeutic Potential for Thyroid Hormone Receptor-β Selective Agonists for Treating Obesity, Hyperlipidemia and Diabetes

Authors: Grover, Gary J.; Mellstrom, Karin; Malm, Johan

Source: Current Vascular Pharmacology, Volume 5, Number 2, April 2007 , pp. 141-154(14)

Publisher: Bentham Science Publishers

Recent Advances in the Development of Agonists Selective for β1-Type Thyroid Hormone Receptor

Authors: Malm, J.; Grover, G. J.; Farnegardh, M.

Source: Mini Reviews in Medicinal Chemistry, Volume 7, Number 1, January 2007 , pp. 79-86(8)

Publisher: Bentham Science Publishers

The Melanocortin System as a Therapeutic Treatment Target for Adiposity and Adiposopathy

Author: Bays, Harold

Source: Drugs in R&D, Volume 7, Number 5, 2006 , pp. 289-302(14)

Publisher: Adis International

Models of glycoprotein hormone receptor interaction

Authors: Moyle, William; Lin, Win; Myers, Rebecca; Cao, Donghui; Kerrigan, John; Bernard, Michael

Source: Endocrine, Volume 26, Number 3, April 2005 , pp. 189-205(17)

Publisher: Humana Press

Editorial [Hot Topic: Nuclear Receptors as Drug Discovery Targets (Executive Editor: Sunil Nagpal)]

Author: Nagpal, Sunil

Source: Mini Reviews in Medicinal Chemistry, Volume 5, Number 8, August 2005 , pp. 699-700(2)

Publisher: Bentham Science Publishers

Human α-subunit analogs act as partial agonists to the thyroid-stimulating hormone receptor: Differential effects of free and yoked subunits

Authors: Angelova, Krassimira; Fremont, Valerie; Jain, Renita; Zhang, Meng; Puett, David; Narayan, Prema; Szkudlinski, Mariusz

Source: Endocrine, Volume 24, Number 1, June 2004 , pp. 25-31(7)

Publisher: Humana Press

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-, reduces acute inflammation

Authors: Cuzzocrea S.; Pisano B.; Dugo L.; Ianaro A.; Maffia P.; Patel N.S.A.; Di Paola R.; Ialenti A.; Genovese T.; Chatterjee P.K.; Di Rosa M.; Caputi A.P.; Thiemermann C.

Source: European Journal of Pharmacology, Volume 483, Number 1, 1 January 2004 , pp. 79-93(15)

Publisher: Elsevier

Pharmacologie du récepteur auxions calcium extracellulaires: Pharmacology of the Calcium Sensing Receptor

Author: Ruat M.

Source: Therapie, Volume 58, Number 5, 2003 , pp. 395-401(7)

Publisher: Adis International